Thank you.
I'll read this quickly. This is to Mr. Sinclair.
The chief trade negotiator informed this committee on November 15 that, regarding drug costs that are being reported, it was:
...very difficult to conduct that kind of analysis, mainly because the types of changes we will see with the changes to the Patent Act, particularly for the additional two years of protection, are not likely to kick in until the agreement has been in place for probably eight years or so.
In your analysis, how did you take into consideration the ongoing efforts of Health Canada working with the provinces to modify or reform our domestic health care system?
Sorry, that's a big question.